Position in URGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$47,912,827
+$20,888,078 QoQ
Shares Held
1,301,979
-13.4% QoQ
Ownership
2.66%
of shares outstanding
% of Portfolio
5.33%
of 13F equity value
Holder Rank
#12
of 190 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in URGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SILVERARC CAPITAL MANAGEMENT, LLC holds $802,586,993 across 53 Biotechnology names. URGN ranks #4 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
206,234 | $55,006,732 | |
| 2 | CELC |
Celcuity Inc.
|
500,996 | $52,414,201 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
1,280,707 | $49,563,360 | |
| 4 | URGN |
UroGen Pharma Ltd.
This page
|
1,301,979 | $47,912,827 | |
| 5 | IMNM |
Immunome Inc.
|
2,017,009 | $42,740,420 | |
| 6 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
390,000 | $38,017,200 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
311,461 | $34,581,514 | |
| 8 | ORKA |
Oruka Therapeutics, Inc.
|
352,802 | $33,576,166 |
All Filings in URGN
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $47,912,827 | 1,301,979 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $27,024,749 | 1,503,045 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $40,723,187 | 1,738,821 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $31,466,795 | 1,577,283 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $27,708,003 | 2,022,482 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $15,275,607 | 1,381,158 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $11,933,037 | 1,120,473 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $11,444,338 | 901,129 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $18,491,560 | 1,102,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,628,805 | 508,587 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,881,060 | 525,404 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,129,450 | 508,883 | Shares | Sole | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||